ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "434122ec-cbcb-4519-b74a-92d2335780fe"}, "_deposit": {"id": "2016897", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "2016897"}, "status": "published"}, "_oai": {"id": "oai:u-ryukyu.repo.nii.ac.jp:02016897", "sets": ["1642838231558", "1642838412624"]}, "author_link": [], "item_1617186331708": {"attribute_name": "Title", "attribute_value_mlt": [{"subitem_1551255647225": "\u9650\u5c40\u6027\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3059\u308b I-125 \u5bc6\u5c01\u5c0f\u7dda\u6e90\u7642\u6cd5150\u4f8b\u306e\u691c\u8a0e", "subitem_1551255648112": "ja"}, {"subitem_1551255647225": "Clinical analysis of brachytherapy with permanent iodine-125 seed implantation for organ-confined prostate cancer in 150 patients", "subitem_1551255648112": "en"}]}, "item_1617186419668": {"attribute_name": "Creator", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "\u5bae\u91cc, \u5b9f", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "\u6709\u8cc0, \u62d3\u90ce", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "\u524d\u672c, \u5747", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "\u8349\u7530, \u6b66\u6717", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "\u82a6\u5208, \u660e\u65e5\u9999", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "\u4e0a\u9593, \u5357\u6d77\u5b50", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "\u5bae\u57ce, \u4eae\u592a", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "\u4ef2\u897f, \u660c\u592a\u90ce", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "\u5449\u5c4b, \u771f\u4eba", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "\u6751\u5c71, \u8c9e\u4e4b", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "\u658e\u85e4, \u8aa0\u4e00", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "Miyazato, Minoru", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Ariga, Takuro", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Maemoto, Hitoshi", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Kusada, Takeaki", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Ashikari, Asuka", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Uema, Namiko", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Miyagi, Ryota", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Nakanishi, Shotaro", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Goya, Masato", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Murayama, Sadayuki", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Saito, Seiichi", "creatorNameLang": "en"}]}]}, "item_1617186476635": {"attribute_name": "Access Rights", "attribute_value_mlt": [{"subitem_1522299639480": "open access", "subitem_1600958577026": "http://purl.org/coar/access_right/c_abf2"}]}, "item_1617186499011": {"attribute_name": "Rights", "attribute_value_mlt": [{"subitem_1522650717957": "ja", "subitem_1522651041219": "\u7409\u7403\u533b\u5b66\u4f1a"}]}, "item_1617186609386": {"attribute_name": "Subject", "attribute_value_mlt": [{"subitem_1522299896455": "en", "subitem_1522300014469": "Other", "subitem_1523261968819": "brachytherapy"}, {"subitem_1522299896455": "en", "subitem_1522300014469": "Other", "subitem_1523261968819": "iodine-125"}, {"subitem_1522299896455": "en", "subitem_1522300014469": "Other", "subitem_1523261968819": "prostate cancer"}]}, "item_1617186626617": {"attribute_name": "Description", "attribute_value_mlt": [{"subitem_description": "Background: We retrospectively evaluated the outcome of brachytherapy with permanent iodine-125 seed implantation for prostate cancer. Methods: From 2009 to2016, 150 patients\uff0849 in low risk, 81 intermediate, 20 high\uff09\uff0cmean age 67.1 y, which were performed brachytherapy in our hospital were enrolled in this study. Results: The average prostate volume was 27.4cc, mean International Prostate Symptom Score 9 in these patients. In postplan evaluation, mean prostate V100 93.8%, D90 in brachytherapy alone 173.9Gy, combined with external beam radiation 116.8Gy, rectum V100 in brachytherapy alone 0.27cc, combined with external beam radiation 0.13cc, urethraD90 in brachytherapy alone 89.9Gy, combined with external beam radiation 64.4Gy. The biochemical progression-free survival in 5 years was 97.0% in low risk, while 96.3% in intermediate and no patients in high risk demonstrated PSA relapse during the observation. Migration of seeds was occurred in 3.3%. Adverse event was urinary retention in 2, hematuria in 2, proctitis in 2, rectal bleeding in 2, more than grade 3 was noted in only one patient. Conclusions: The outcome of brachytherapy in our hospital was safe and feasible with low side effects.", "subitem_description_type": "Other"}, {"subitem_description": "\u8ad6\u6587", "subitem_description_type": "Other"}]}, "item_1617186643794": {"attribute_name": "Publisher", "attribute_value_mlt": [{"subitem_1522300295150": "ja", "subitem_1522300316516": "\u7409\u7403\u533b\u5b66\u4f1a"}, {"subitem_1522300295150": "en", "subitem_1522300316516": "Ryukyu Medical Association"}]}, "item_1617186702042": {"attribute_name": "Language", "attribute_value_mlt": [{"subitem_1551255818386": "jpn"}]}, "item_1617186920753": {"attribute_name": "Source Identifier", "attribute_value_mlt": [{"subitem_1522646500366": "ISSN", "subitem_1522646572813": "1346-888X"}, {"subitem_1522646500366": "NCID", "subitem_1522646572813": "AN10369445"}]}, "item_1617186941041": {"attribute_name": "Source Title", "attribute_value_mlt": [{"subitem_1522650068558": "ja", "subitem_1522650091861": "\u7409\u7403\u533b\u5b66\u4f1a\u8a8c = Ryukyu Medical Journal"}]}, "item_1617187056579": {"attribute_name": "Bibliographic Information", "attribute_value_mlt": [{"bibliographicIssueNumber": "1-4", "bibliographicPageEnd": "17", "bibliographicPageStart": "13", "bibliographicVolumeNumber": "37"}]}, "item_1617258105262": {"attribute_name": "Resource Type", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_1617265215918": {"attribute_name": "Version Type", "attribute_value_mlt": [{"subitem_1522305645492": "VoR", "subitem_1600292170262": "http://purl.org/coar/version/c_970fb48d4fbd8a85"}]}, "item_1617605131499": {"attribute_name": "File", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_access", "download_preview_message": "", "file_order": 0, "filename": "Vol37(1-4)p13.pdf", "future_date_message": "", "is_thumbnail": false, "mimetype": "", "size": 0, "url": {"objectType": "fulltext", "url": "https://u-ryukyu.repo.nii.ac.jp/record/2016897/files/Vol37(1-4)p13.pdf"}, "version_id": "57ba5324-5358-47b4-881c-16db37ec1223"}]}, "item_title": "\u9650\u5c40\u6027\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3059\u308b I-125 \u5bc6\u5c01\u5c0f\u7dda\u6e90\u7642\u6cd5150\u4f8b\u306e\u691c\u8a0e", "item_type_id": "15", "owner": "1", "path": ["1642838231558", "1642838412624"], "permalink_uri": "http://hdl.handle.net/20.500.12000/0002016897", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2019-11-29"}, "publish_date": "2019-11-29", "publish_status": "0", "recid": "2016897", "relation": {}, "relation_version_is_last": true, "title": ["\u9650\u5c40\u6027\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3059\u308b I-125 \u5bc6\u5c01\u5c0f\u7dda\u6e90\u7642\u6cd5150\u4f8b\u306e\u691c\u8a0e"], "weko_shared_id": -1}
  1. 学術雑誌論文
  2. 琉球医学会
  3. 琉球医学会誌
  4. 37巻1-4号
  1. 部局別インデックス
  2. その他

限局性前立腺癌に対する I-125 密封小線源療法150例の検討

http://hdl.handle.net/20.500.12000/0002016897
http://hdl.handle.net/20.500.12000/0002016897
7b0e79f2-3cd7-4100-a84f-5711530a03d0
名前 / ファイル ライセンス アクション
Vol37(1-4)p13.pdf Vol37(1-4)p13.pdf
Item type デフォルトアイテムタイプ(フル)(1)
公開日 2019-11-29
タイトル
タイトル 限局性前立腺癌に対する I-125 密封小線源療法150例の検討
言語 ja
作成者 宮里, 実

× 宮里, 実

ja 宮里, 実

有賀, 拓郎

× 有賀, 拓郎

ja 有賀, 拓郎

前本, 均

× 前本, 均

ja 前本, 均

草田, 武朗

× 草田, 武朗

ja 草田, 武朗

芦刈, 明日香

× 芦刈, 明日香

ja 芦刈, 明日香

上間, 南海子

× 上間, 南海子

ja 上間, 南海子

宮城, 亮太

× 宮城, 亮太

ja 宮城, 亮太

仲西, 昌太郎

× 仲西, 昌太郎

ja 仲西, 昌太郎

呉屋, 真人

× 呉屋, 真人

ja 呉屋, 真人

村山, 貞之

× 村山, 貞之

ja 村山, 貞之

斎藤, 誠一

× 斎藤, 誠一

ja 斎藤, 誠一

Miyazato, Minoru

× Miyazato, Minoru

en Miyazato, Minoru

Ariga, Takuro

× Ariga, Takuro

en Ariga, Takuro

Maemoto, Hitoshi

× Maemoto, Hitoshi

en Maemoto, Hitoshi

Kusada, Takeaki

× Kusada, Takeaki

en Kusada, Takeaki

Ashikari, Asuka

× Ashikari, Asuka

en Ashikari, Asuka

Uema, Namiko

× Uema, Namiko

en Uema, Namiko

Miyagi, Ryota

× Miyagi, Ryota

en Miyagi, Ryota

Nakanishi, Shotaro

× Nakanishi, Shotaro

en Nakanishi, Shotaro

Goya, Masato

× Goya, Masato

en Goya, Masato

Murayama, Sadayuki

× Murayama, Sadayuki

en Murayama, Sadayuki

Saito, Seiichi

× Saito, Seiichi

en Saito, Seiichi

アクセス権
アクセス権 open access
アクセス権URI http://purl.org/coar/access_right/c_abf2
権利情報
言語 ja
権利情報 琉球医学会
主題
言語 en
主題Scheme Other
主題 brachytherapy
言語 en
主題Scheme Other
主題 iodine-125
言語 en
主題Scheme Other
主題 prostate cancer
内容記述
内容記述タイプ Other
内容記述 Background: We retrospectively evaluated the outcome of brachytherapy with permanent iodine-125 seed implantation for prostate cancer. Methods: From 2009 to2016, 150 patients(49 in low risk, 81 intermediate, 20 high),mean age 67.1 y, which were performed brachytherapy in our hospital were enrolled in this study. Results: The average prostate volume was 27.4cc, mean International Prostate Symptom Score 9 in these patients. In postplan evaluation, mean prostate V100 93.8%, D90 in brachytherapy alone 173.9Gy, combined with external beam radiation 116.8Gy, rectum V100 in brachytherapy alone 0.27cc, combined with external beam radiation 0.13cc, urethraD90 in brachytherapy alone 89.9Gy, combined with external beam radiation 64.4Gy. The biochemical progression-free survival in 5 years was 97.0% in low risk, while 96.3% in intermediate and no patients in high risk demonstrated PSA relapse during the observation. Migration of seeds was occurred in 3.3%. Adverse event was urinary retention in 2, hematuria in 2, proctitis in 2, rectal bleeding in 2, more than grade 3 was noted in only one patient. Conclusions: The outcome of brachytherapy in our hospital was safe and feasible with low side effects.
内容記述タイプ Other
内容記述 論文
出版者
言語 ja
出版者 琉球医学会
言語
言語 jpn
資源タイプ
資源タイプ journal article
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
収録物識別子
収録物識別子タイプ ISSN
収録物識別子 1346-888X
収録物識別子タイプ NCID
収録物識別子 AN10369445
収録物名
言語 ja
収録物名 琉球医学会誌 = Ryukyu Medical Journal
書誌情報
巻 37, 号 1-4, p. 13-17
戻る
0
views
See details
Views

Versions

Ver.1 2022-02-22 07:18:58.762182
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON

確認


Powered by WEKO3


Powered by WEKO3